万方数据万方数据万方数据恶性嗜铬细胞瘤的诊断进展作者：钟旭， 王卫庆， Zhong Xu， Wang Weiqing作者单位：200025 上海交通大学医学院附属瑞金医院内分泌代谢病科,上海市内分泌代谢病临床医学中心,上海市内分泌代谢病研究所刊名：中华内分泌代谢杂志英文刊名：Chinese Journal of Endocrinology and Metabolism年，卷(期)：2014,30(6)1.Korevaar TI;Grossman AB Pheochromocytomas and paragangliomas:assessment of malignant potential 20112.Ayala-Ramirez M;Feng L;Johnson MM Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas:primary tumor size and primary tumor location as prognostic indicators 20113.van der Harst E;de Herder W;de Krijger R The value of plasma markers for the clinical behaviour of phaeochromocytomas 20024.Gimm O;De Micco C;Perren A Malignant pheochromocytomas and paragangliomas:a diagnostic challenge 20125.Harari A;Inabnet Ⅲ WB Malignant pheochromocytoma:a review 20116.Eisenhofer G;Lenders JWM;Siegert G Plasma methoxytyramine:A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size,location and SDHB mutation status 20127.Ezuddin S;Fragkaki C MIBG and FDG PET findings in a patient with malignant pheochromocytoma:a significant discrepancy 20058.Bias I;Pacak K Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma 20049.Ilias I;Yu J;Carrasquillo JA Superiority of 6-[18F]-fluorodopamine positron emission tomography versus[131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma 200310.Timmers HJ;Chen CC;Carrasquillo JA Comparison of 18F-fluoro-L-DOPA,18F-fluoro-deoxyglucose,and 18F-fluorodopamine PET and 123 I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma 200911.Takano A;Oriuchi N;Tsushima Y Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging:comparison with 18 F-FDG positron emission tomography and 123I-MIBG scintigraphy 200812.Zelinka T;Musil Z;Du(s)ková J Metastatic pheochromocytoma:Does the size and age matter 201113.de Wailly P;Oragano L;Radé F Malignant pheochromocytoma:new malignancy criteria 201214.Thompson LDR Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms:a clinicopathologic and immunophenotypic study of 100 cases 200215.Agarwal A;Mehrotra PK;Jain M Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS):can they predict malignancy 201016.Wo D;Tischler AS;Lloyd RV Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score 200917.Astuti D;Latif F;Dallol A Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma 200118.Gimenez-Roqueplo AP;Favier J;Rustin P Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas 200319.Neumann HP;Pawlu C;Peczkowska M Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations 200420.van Nederveen FH;Gaal J;Favier J An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB,SDHC,or SDHD gene mutations:a retrospective and prospective analysis 200921.Blank A;Schmitt AM;Korpershoek E SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas,but not through hypoxia signalling 201022.Yuan WQ;Wang WQ;Cui B Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry 200823.Qi Y;Su T;Zhang X Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity 201224.Zhang B;Pan X;Cobb GP microRNAs as oncogenes and tumor suppressors 200725.Meyer-Rochow GY;Jackson NE;Conaglen JV microRNA profiling of benign and malignant pheochromocytomas identifies novel diagnosfic and therapeutic targets 201026.Tombol Z;Eder K;Kovacs A microRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas 201027.Patterson E;Webb R;Weisbrod A The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma 201228.Kalluri R;Weinberg RA The basics of epithelial-mesenchymal transition 200929.Waldmann J;Slater EP;Langer P Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas 200930.Loriot C;Burnichon N;Gadessaud N Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations 201231.Sandgren J;de St?hl TD;Andersson R Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis 201032.Waldmann J;Fendrich V;Holler J Microarray analysis reveals differential expression of benign and malignant pheochromocytoma 201033.Korpershoek E;Stobbe CK;van Nederveen FH Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas 201034.Burnichon N;Vescovo L;Amar L Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma 2011引用本文格式：钟旭.王卫庆.Zhong Xu.Wang Weiqing恶性嗜铬细胞瘤的诊断进展[期刊论文]-中华内分泌代谢杂志 2014(6)。